Health

3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling

REYKJAVIK, Iceland and BERLIN, Aug. 18, 2023 /PRNewswire/ -- Reykjavik-based drug discovery company, 3Z, andGermany/US-based causal AI firm, biotx.ai, have joined forces in a strategic partnership aimed at revolutionizing ADHD drug development. By leveraging advanced AI modelling techniques, the ...

2023-08-18 22:45 2865

VIGILL Triumphs as "Excellence in Women's Intimate Hygiene Products Brand" at The LICTA 2022 Awards

KUALA LUMPUR, Malaysia, Aug. 18, 2023 /PRNewswire/ -- VIGILL, Taiwan's leading women's intimate care brand, proudly announces its recognition as the "Excellence in Women's Intimate Hygiene Products Brand" at the 5th Lang International Corporate Titan Awards (LICTA 2022) inMalaysia. VIGILL stands ...

2023-08-18 19:15 5139

QiLu Pharmaceutical's Iruplinalkib Phase III INSPIRE Study Researched Primary Endpoint and was Selected for 2023 WCLC Oral Presentation

JINAN, China, Aug. 18, 2023 /PRNewswire/ -- August 16, 2023, at the 2023 World Conference on Lung Cancer (WCLC), the complete list of selected abstracts was announced, among which QiLu Pharmaceutical's iruplinalkib phase III clinical trial (INSPIRE) results were chosen for oral presentation at th...

2023-08-18 09:50 2460

Everest Medicines' Partner Calliditas Therapeutics Announces Full Results From NefIgArd Phase 3 Trial published in The Lancet

SHANGHAI, Aug. 18, 2023 /PRNewswire/ -- Everest Medicines' (HKEX 1952.HK, "Everest", or the "Company") partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced the publication inThe Lancet of the full data from the NeflgArd Phase 3 trial with Nefecon® in...

2023-08-18 08:41 2444

BoomerangFX expands into Australian Market Driven by Growing Demand for Aesthetic Medicine Services in Asia Pacific

Responding to Growing Customer Demand – Cloud-Based Clinic Software, Digital Marketing & eLearning Provider Makes Significant Advances in the Australian Market TORONTO and MIAMI, Aug. 17, 2023 /PRNewswire/ -- BoomerangFX, a global provider of Software as a Service (SaaS), specializing in compreh...

2023-08-18 00:01 1544

Capco's Singapore 2023 insurance survey highlights opportunities for insurers to use innovative data and personalization strategies to meet evolving customer needs

Consumers favor more personalized products and are willing to share additional personal data with insurers to secure benefits, including an enhanced claims process and cheaper premiums Insurers need to consider long-established customer imperatives such as affordability, value for money and a pr...

2023-08-17 10:00 1960

Novo Holdings participates in $290m strategic financing of Sangon Biotech

COPENHAGEN, Denmark, Aug. 17, 2023 /PRNewswire/ -- Novo Holdings, a leading international life science investor, today announced it has participated in a $290 million (USD) strategic financing round of Sangon Biotech. Sangon is a leading provider of life science tools and services, enabling scient...

2023-08-17 09:44 2240

TraceLink Collaborates with GS1 US to Author GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3 to Support EPCIS Data Exchange

Publication of the GS1 standard guidelines and technical examples provide a strong foundation to help companies accelerate their network connectivity and EPCIS-based sTI/TS data exchange to meet forthcomingNovember 2023 DSCSA deadlines. BOSTON, Aug. 17, 2023 /PRNewswire/ -- TraceLink Inc., the l...

2023-08-17 09:35 1379

Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...

2023-08-17 08:00 3244

Global Leading Health Company JUNG KWAN JANG Participates in "William Jones Cup" after 4-year Gap

TAIPEI, Aug. 17, 2023 /PRNewswire/ -- Korea Ginseng Corporation's JUNG KWAN JANG basketball team will compete in the William Jones Cup International Basketball Tournament to be held inTaiwan from August 12. They will represent South Korea as the men's basketball team and compete against foreign t...

2023-08-17 08:00 2559

Oncoclínicas Group generated record earnings in the second quarter of 2023, R$309 million and a net profit of R$35 million

Efficient management of working capital explains a large part of the cash flow performance. Net income grew 51% (31% organically) while the Ebitda Ex-LTIP (excluding only the non-cash impact of the long-term incentive plan) reached R$268 million, 109% greater than the same period last year SÃO PA...

2023-08-16 19:00 1984

"Pink Walk 2023" - signature charity walk of Hong Kong Breast Cancer Foundation is making a comeback on 15 October at the Peak

"Step Up for Breast Health"! HONG KONG, Aug. 16, 2023 /PRNewswire/ -- The Hong Kong Breast Cancer Foundation (HKBCF), is delighted to announce that its annual signature fundraising event"Pink Walk 2023" is making a comeback on 15 October 2023 (Sunday) at The Peak,Hong Kong Island. Themed "Step U...

2023-08-16 17:16 2456

Record number of participants expected at Medlab Asia & Asia Health 2023

BANGKOK, Aug. 16, 2023 /PRNewswire/ -- Medlab Asia & Asia Health 2023, organised by Informa Markets and IMPACT Exhibition Management in collaboration with the Central Sterilizing Services Association, has officially opened to showcase the latest techniques and innovations in the healthcare and lab...

2023-08-16 16:08 2522

Nippon Express (Ireland) Opens New Warehouse in Dublin, Beginning Operations July 1

TOKYO, Aug. 16, 2023 /PRNewswire/ -- Nippon Express (Ireland) Ltd. (hereafter "NX Ireland"), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a new warehouse, "Contract Logistics Center," inDublin city, beginning its operations onJuly 1. Logo: https://kyodonewsprwire.jp/img/2023...

2023-08-16 14:00 1859

Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug' Launching 'Fexuprazan' in the Philippines

'Fexuprazan,' Novel drug for Gastroesophageal Reflux Disease, starts its release inthe Philippines... The first case of overseas launch SEOUL, South Korea, Aug. 16, 2023 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Jeon Seng-ho, Lee Chang-jae) announced that 'Fuxuprazan' is officially launched i...

2023-08-16 13:00 2665

MGI Unveils Latest MGISP-NEX and MGIFLP-L50 Automation Systems at Medlab Asia & Asia Health 2023

BANGKOK, Thailand, Aug. 16, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the global launch of MGISP-NEX and MGIFLP-L50 automation platforms at Medlab Asia & Asia Health 2023, taking place from 16-18 August at IMPACT E...

2023-08-16 11:00 2416

GLENEAGLES HOSPITAL MEDINI JOHOR AND THE INTERNATIONAL WOMEN'S PEACE GROUP ORGANIZE TALK FOR 200 JOHOR EDUCATORS

Key Speakers Provide Invaluable Insights for Addressing Adolescent Reproductive Health Issues ISKANDAR PUTERI, Malaysia, Aug. 16, 2023 /PRNewswire/ -- Gleneagles Hospital Medini Johor (GHMJ) and the International Women's Peace Group (IWPG) have reaffirmed their shared commitment to the well...

2023-08-16 10:59 2180

Charmacy Pharmaceutical Has Obtained the Provincial Capital Support

Future Expected Rapidly Growth  HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Charmacy Pharmaceutical Co., LTD. ( Charmacy Pharmaceutical, stock code: 2289.HK), as a leading private pharmaceutical distributor inSouth China, has been actively seeking strategic cooperation and resource complementary fro...

2023-08-16 09:00 3822

Infinitus and Jiangnan University Establish an Innovation Research Center to Explore the Combination of Chinese Herbal Medicine and Probiotics

GUANGZHOU, China, Aug. 16, 2023 /PRNewswire/ -- On August 10, the signing and inauguration ceremony ofthe Infinitus-Jiangnan University Chinese Herbal + Probiotics Collaborative Innovation Research Center was held at Infinitus Plaza.

2023-08-16 08:00 2255

Transcenta to Present Three Study Results at ESMO 2023

SUZHOU, China, Aug. 16, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it is going to ...

2023-08-16 08:00 1943
1 ... 131132133134135136137 ... 581